EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineering a 660 nm‐Responsive Optogenetic Inducer of Pyroptosis for Precision Cancer Therapy

Mengkai Zhang iD, Zhichao Li iD, Yonghao Ma, Yangyang Sun iD, Wei Chen, Weiren Huang iD

Advanced Science · 2026

DOI: 10.1002/advs.76768 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Mengkai Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Innovation Technology Transformation Center, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Institu…. Hauptthemen laut MEDLINE: Pyroptosis, Optogenetics, Neoplasms. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Shenzhen Medical Research Fund, Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inducing tumor cell pyroptosis represents a promising anticancer strategy; however, uncontrolled pyroptosis not only restricts the production of viral delivery vectors but also poses a risk of systemic damage, thereby limiting the translational application of pyroptosis‐based therapies. The development of genetic tools that enable precise spatiotemporal control over pyroptosis remains challenging. To address this, we developed PyroRACS, a bioorthogonal optogenetic inducer for precise pyroptosis induction. PyroRACS utilizes an engineered red‐light‐activatable Cre‐ON genetic switch (RACS) to drive the expression of the gasdermin D N‐terminal domain, enabling tunable initiation of pyroptosis without relying on endogenous signaling pathways. We validated robust pyroptosis induction by PyroRACS in multiple cell lines. PyroRACS exhibited high controllability by selectively ablating cancer cells in vitro with precise spatiotemporal resolution. Moreover, its superior controllability enabled the production of the adenovirus vector and allowed “all‐in‐one” delivery of PyroRACS. In a tumor‐bearing mouse model, spatially restricted induction of pyroptosis by PyroRACS resulted in effective tumor suppression, with no detectable systemic toxicity observed under the tested conditions. Collectively, PyroRACS provides a novel optogenetic tool for precise manipulation of pyroptosis, facilitating fundamental research and advancing pyroptosis‐based precision oncology therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisOptogeneticsNeoplasmsAnimalsHumansMiceRed LightCell Line, Tumor

Stichwörter der Autor:innen

PyroRACScontrollable pyroptosisoptogeneticsprecise tumor therapysynthetic biology

Autor:innen und Institutionen

  • Medical Innovation Technology Transformation Center, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Institute for Advanced Study, Synthetic Biology Research Center, Shenzhen Uni…
  • School of Biomedical Engineering, Shenzhen University, Shenzhen, People's Republic of China.
  • Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People's Republic of China.

ORCID-Profile: Mengkai Zhang, Zhichao Li, Yangyang Sun, Weiren Huang

Förderung

  • National Key R&D Program of China
  • Shenzhen Medical Research Fund
  • Natural Science Foundation of China
  • Shenzhen Portion of Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone
  • Guangdong Engineering Technology Research Center for Clinical Application of Cancer Genome
  • Guangzhou Key R&D Program
  • Research Fund of the Synthetic Biology Research Center of Shenzhen University
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, M., Li, Z., Ma, Y., Sun, Y., Chen, W., & Huang, W. (2026). Engineering a 660 nm‐Responsive Optogenetic Inducer of Pyroptosis for Precision Cancer Therapy. Advanced Science. https://doi.org/10.1002/advs.76768

Vancouver

Zhang M, Li Z, Ma Y, Sun Y, Chen W, Huang W. Engineering a 660 nm‐Responsive Optogenetic Inducer of Pyroptosis for Precision Cancer Therapy. Advanced Science. 2026. doi:10.1002/advs.76768

BibTeX
@article{Zhang2026,
  author = {Zhang, Mengkai and Li, Zhichao and Ma, Yonghao and Sun, Yangyang and Chen, Wei and Huang, Weiren},
  title = {Engineering a 660 nm‐Responsive Optogenetic Inducer of Pyroptosis for Precision Cancer Therapy},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76768}
}
Kostenlos starten →